Which of the following is false about Pramlinitide?
- Used in Type 1 and Type 2 DM
- Acts through Amylin receptor
- increases insulin release
- causes weight loss
answer: increases insulin release
ref: GG 13E/P 886
Pramlintide:
acts through the amylin receptor
- reduces glucagon secretion
- delays gastric emptying
- feeling of satiety is seen
- doesn’t increase insulin release
Adverse Effects:
- nausea and hypoglycemia(MC)( when used with insulin)
Therapeutic Uses.:
- approved for treatment of types 1 and 2 diabetes as an adjunct in patients who take insulin with meals
For more MCQs and concepts become pro member by clicking below
https://drpharmacologist.testpress.in/products/pro-members/